Literature DB >> 33045727

GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences.

Shuyi Fang1, Kailing Li1, Jikui Shen2, Sheng Liu3,4, Juli Liu5, Lei Yang5, Chang-Deng Hu6,7, Jun Wan1,3,4,8.   

Abstract

The COVID-19 outbreak has become a global emergency since December 2019. Analysis of SARS-CoV-2 sequences can uncover single nucleotide variants (SNVs) and corresponding evolution patterns. The Global Evaluation of SARS-CoV-2/hCoV-19 Sequences (GESS, https://wan-bioinfo.shinyapps.io/GESS/) is a resource to provide comprehensive analysis results based on tens of thousands of high-coverage and high-quality SARS-CoV-2 complete genomes. The database allows user to browse, search and download SNVs at any individual or multiple SARS-CoV-2 genomic positions, or within a chosen genomic region or protein, or in certain country/area of interest. GESS reveals geographical distributions of SNVs around the world and across the states of USA, while exhibiting time-dependent patterns for SNV occurrences which reflect development of SARS-CoV-2 genomes. For each month, the top 100 SNVs that were firstly identified world-widely can be retrieved. GESS also explores SNVs occurring simultaneously with specific SNVs of user's interests. Furthermore, the database can be of great help to calibrate mutation rates and identify conserved genome regions. Taken together, GESS is a powerful resource and tool to monitor SARS-CoV-2 migration and evolution according to featured genomic variations. It provides potential directive information for prevalence prediction, related public health policy making, and vaccine designs.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2021        PMID: 33045727     DOI: 10.1093/nar/gkaa808

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Bioinformatics for the Origin and Evolution of Viruses.

Authors:  Jiajia Chen; Yuxin Zhang; Bairong Shen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries.

Authors:  Yosef Masoudi-Sobhanzadeh; Aysan Salemi; Mohammad M Pourseif; Behzad Jafari; Yadollah Omidi; Ali Masoudi-Nejad
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

3.  The 2021 Nucleic Acids Research database issue and the online molecular biology database collection.

Authors:  Daniel J Rigden; Xosé M Fernández
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

4.  SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity.

Authors:  Juliana D Siqueira; Livia R Goes; Brunna M Alves; Pedro S de Carvalho; Claudia Cicala; James Arthos; João P B Viola; Andréia C de Melo; Marcelo A Soares
Journal:  Virus Evol       Date:  2021-02-16

Review 5.  SARS-CoV-2: from its discovery to genome structure, transcription, and replication.

Authors:  Ayslan Castro Brant; Wei Tian; Vladimir Majerciak; Wei Yang; Zhi-Ming Zheng
Journal:  Cell Biosci       Date:  2021-07-19       Impact factor: 7.133

6.  IDbSV: An Open-Access Repository for Monitoring SARS-CoV-2 Variations and Evolution.

Authors:  Abdelmounim Essabbar; Souad Kartti; Tarek Alouane; Mohammed Hakmi; Lahcen Belyamani; Azeddine Ibrahimi
Journal:  Front Med (Lausanne)       Date:  2021-12-13

Review 7.  Does COVID-19 Vaccination Warrant the Classical Principle "ofelein i mi vlaptin"?

Authors:  Michael Doulberis; Apostolis Papaefthymiou; Georgios Kotronis; Dimitra Gialamprinou; Elpidoforos S Soteriades; Anthony Kyriakopoulos; Eleftherios Chatzimichael; Kyriaki Kafafyllidou; Christos Liatsos; Ioannis Chatzistefanou; Paul Anagnostis; Vitalii Semenin; Smaragda Ntona; Ioanna Gkolia; Dimitrios David Papazoglou; Nikolaos Tsinonis; Spyros Papamichos; Hristos Kirbas; Petros Zikos; Dionisios Niafas; Jannis Kountouras
Journal:  Medicina (Kaunas)       Date:  2021-03-09       Impact factor: 2.430

8.  Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2.

Authors:  Mohammad Afsar; Rohan Narayan; Md Noor Akhtar; Deepakash Das; Huma Rahil; Santhosh Kambaiah Nagaraj; Sandeep M Eswarappa; Shashank Tripathi; Tanweer Hussain
Journal:  Elife       Date:  2022-03-24       Impact factor: 8.713

Review 9.  Comprehensive Survey of Using Machine Learning in the COVID-19 Pandemic.

Authors:  Nora El-Rashidy; Samir Abdelrazik; Tamer Abuhmed; Eslam Amer; Farman Ali; Jong-Wan Hu; Shaker El-Sappagh
Journal:  Diagnostics (Basel)       Date:  2021-06-24

10.  Early-stage spatial disease surveillance of novel SARS-CoV-2 variants of concern in Germany with crowdsourced data.

Authors:  Timo Mitze; Johannes Rode
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.